Abstract:Parkinson’s disease (PD) is a multifaceted progressive neurodegenerative disease that includes a broad range of motor and non-motor symptoms (NMS). Autonomic nervous system (ANS) dysfunction is associated with a number of common NMS in PD that exert a profound impact on quality of life and increase the risk of mortality. ANS dysfunction, which likely precedes the onset of motor symptoms, includes changes in heart rate variability (HRV) that reflect pathological adjustments in the balance between sympathetic (SNS) and parasympathetic (PNS; vagal) influences on heart rate control. While the primary neuropathology of PD is related to the loss of dopamine neurons in the nigrostriatal pathway, serotonergic (5-HT) dysfunction also appears to play a role in the development of some motor and NMS and complications in PD. 5-HT is also known to play a critical role in cardiovascular (cardiac) regulation; thus, autonomic dysfunction in PD may be further complicated by 5-HT dysfunction. To begin to address this possibility, we investigated HRV quantified from 5-min segments of continuously recorded ECG activity before and after acute systemic administration of the 5-HT 1A receptor agonist 8-OH-DPAT (DPAT) in urethane-anesthetized adult female rats at 2-weeks after unilateral injection of the neurotoxin 6-OHDA (n=11) or vehicle (VEH; n=7) directly into the substantia nigra (SN). HRV measures evaluated included standard deviation (SD) of R-R intervals (SDRR) and root mean square of successive differences in R-R (RMSSD) as time-domain measures; absolute (abs) and normalized (nu) low-frequency (LF: 0.2-0.75 Hz) and high-frequency (HF: 0.75-3.0 Hz) spectral power and the LF/HF ratio as frequency domain measures; and Poincaré plot SD perpendicular to (SD1) and along (SD2) the line of identity and the SD1/SD2 ratio as non-linear measures. For these analyses, SDRR, LF, and SD2 were considered indices of mixed cardiac SNS and PNS activity; RMSSD, HF, and SD1 were considered indices of PNS activity; and LF/HF and SD1/SD2 were considered indices of sympatho-vagal balance. Before DPAT (compared to VEH-injected rats), 6-OHDA-injected rats exhibited slightly but not significantly higher HR and lower SDRR, RMSSD, abs and nu LF power, abs HF power, LF/HF ratio, SD1, and SD2, but the R-R interval, nu HF power, and SD1/SD2 ratio were similar between the groups. Following DPAT administration, both 6-OHDA- and VEH-injected rats exhibited significantly reduced HR by ~15% and increased R-R intervals by 20%. In 6-OHDA-injected rats, DPAT also increased SDRR, RMSSD, abs HF power, SD1, and the SD1/SD2 ratio but significantly reduced nu HF power; similar trends were noted in VEH-injected rats. These data demonstrate that while most HRV measures are minimally altered under baseline conditions, 5-HT 1A receptor activation can significantly alter autonomic balance and HRV metrics (especially measures associated with PNS activity) in the SN 6-OHDA-induced lesion rat model of PD. NIH NS101737; Thomas Hartman Center for Parkinson's Disease Research at Stony Brook University This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Impaired circadian heart rate variability in Parkinson’s disease: a time-domain analysis in ambulatory setting

1002 Heart Rate Variability During Sleep and Future Risk of Parkinson’s Disease in Community-dwelling Older Men

Association Between Heart Rate Variability and Parkinson’s Disease: A Meta-analysis

Decreased Heart Rate Variability in Sympathetic Dominant States in Parkinson's Disease and Isolated REM Sleep Behavior Disorder

Sympathetic Skin Response and Heart Rate Variability in Predicting Autonomic Disorders in Patients with Parkinson Disease

Clinical Analysis of Heart Rate Variability in Parkinson's Disease

Chronotropic Incompetence During Exercise Testing as a Marker of Autonomic Dysfunction in Individuals with Early Parkinson's Disease

Nocturnal hypertension and dysautonomia in patients with Parkinson’s disease: are they related?

Reproducibility of Heart Rate Variability Revealed by Repeated Measurements during and after Hemodialysis

Heart rate variability in Parkinson disease and idiopathic REM sleep behavior disorder

Evaluation of Cardiovascular Autonomic Nervous System in Essential Tremor and Tremor Dominant Parkinson's Disease

Nocturnal Heart Rate Variability Might Help in Predicting Severe Obstructive Sleep-Disordered Breathing

Reduction in Heart Rate Variability in Autosomal Dominant Polycystic Kidney Disease

Assessment of Autonomic Dysfunction in Patients with Parkinson's Disease

24-hour ambulatory blood pressure alterations in patients with Parkinson's disease

Different Impact of Heart Rate Variability in the Deep Cerebral and Central Hemodynamics at Rest: An in silico Investigation

Cardiac and Autonomic Dysfunctions Assessed Through Recurrence Quantitative Analysis of Electrocardiogram Signals and an Application to the 6-Hydroxydopamine Parkinson’s Disease Animal Model

Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy

Serotonin (5-HT)-1A receptor activation alters heart rate variability (HRV) in SN 6-OHDA-induced rat model of Parkinson's Disease

Circadian Rest-Activity Rhythms Predict Cognitive Function in Early Parkinson's Disease Independently of Sleep

Sympathetic dysfunction as an early indicator of autonomic involvement in Parkinson's disease